Plasma suPAR levels among patients with IgAN, primary FSGS, secondary FSGS, MN, MCD, and healthy controls.

<p>Plasma suPAR levels of patients with IgA nephopathy (IgAN, 2298, IQR 1776–2956 pg/mL) were significantly lower than patients with primary FSGS (FSGS, 2923, interquartile range (IQR) 2205–4360 pg/mL, <i>P</i> < 0.001), higher than those with membranous nephropathy (MN, 2028, IQR 1512–2715, <i>P</i> = 0.045), minimal change disease (MCD, 2050, IQR 1813–2249 pg/mL, <i>P</i> = 0.001), and healthy controls (HC, 1739, 1513–2121 pg/mL, <i>P</i> < 0.001), respectively. There was no significant difference in plasma suPAR levels between patients with IgA nephrology and patients with secondary FSGS (FSGS, 2639, IQR 1945–3166 pg/mL, <i>P</i> = 0.621).